Responses to COVID-19 Vaccines in Cancer Patients: Impact of Tumor and Treatment Type
Most patients with solid tumors demonstrate immune responses to COVID-19 vaccines, but a subset of patients do not.
Most patients with solid tumors demonstrate immune responses to COVID-19 vaccines, but a subset of patients do not.
Experts outline benefits and detriments of COVID-19 vaccine mandates.
The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.
Frail survivors of childhood cancer experienced greater neurocognitive decline.
About 31% of the articles analyzed contained information classified as harmful.
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future.
New guidelines recommend using the full approved doses of immunotherapy and targeted therapies for patients with cancer and obesity.
Researchers present data on use of palliative care in the last 30 days of life and the impact on costs among those who did and did not receive palliative care.
Patients living in states with lower eligibility limits had worse survival rates, regardless of cancer stage at diagnosis.